Nicholas M Romano Jr., MD Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 104 S 2nd St, Bangor, PA 18013 Phone: 610-588-3133 Fax: 610-588-5138 |
Vaghenag Vahe Tarpinian, MD Family Medicine Medicare: Medicare Enrolled Practice Location: 104 S 2nd St, Bangor, PA 18013 Phone: 610-588-3133 Fax: 610-588-6251 |
News Archive
Teva Pharmaceuticals Industries Ltd. and OncoGenex Pharmaceuticals, Inc. announced today the initiation of SYNERGY, a global Phase 3 trial evaluating custirsen (also known as OGX-011/TV-1011) as first line therapy for the treatment of castrate-resistant prostate cancer (CRPC).
Lawrence Wetsit misses the days when his people would gather by the hundreds and sing the songs that all Assiniboine children are expected to learn by age 15.
In recent years, researchers have identified substances in coffee that could help quash the risk of developing Type 2 diabetes. But few of these have been tested in animals. Now in study appearing in ACS' Journal of Natural Products, scientists report that one of these previously untested compounds appears to improve cell function and insulin sensitivity in laboratory mice.
Today's headlines include reports about a federal judge's ruling regarding the Virginia challenge to the health reform law and about the Senate's latest delay in consideration of a state aid package that includes Medicaid assistance.
In what the researchers say could be promising news in the quest to find a therapy to slow the progression of amyotrophic lateral sclerosis (ALS), or Lou Gehrig's disease, scientists at the University of California, San Diego (UCSD) School of Medicine have shown that targeting neuronal support cells called astrocytes sharply slows disease progression in mice.
› Verified 7 days ago